Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of Synechococcus elongatus wild type, K10 and MuD mutants growth with or without Fe
Synechococcus elongatus PCC7942 wild type, the IdiB-free S.elongatus mutant K10 (Michel et al. 1999; Microbiology, 145: page 1473-1484) and the IdiC-merodiploid mutant MuD (Pietsch et al. 2007, Photosynth. Res. 94: page 91-108) were cultivated in BG11 medium, continuously bubbled with 2%CO2-enriched...
ORGANISM(S): Synechococcus elongatus 
2008-07-13 | E-MEXP-1657 | biostudies-arrayexpress
UnknownDiversification of habenular organization and asymmetries in teleosts: Insights from the Atlantic salmon and European eel.
Not available
S-EPMC9671474 | biostudies-literature
UnknownSalmon Food-Specific Compounds and Their Metabolites Increase in Human Plasma and Are Associated with Cardiometabolic Health Indicators Following a Mediterranean-Style Diet Intervention.
Not available
S-EPMC10808825 | biostudies-literature
UnknownConnexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis.
Not available
S-EPMC1851033 | biostudies-literature
TranscriptomicsTranscription profiling of human neurofibromatosis type 1
Genes involved in tumorigenesis associated with neurofibromatosis type 1.
ORGANISM(S): Homo sapiens 
2007-01-12 | E-TABM-69 | biostudies-arrayexpress
TranscriptomicsLeishmania donovani amastigotes: Nelfinavir (NFV)-sensitive (control) vs Nelfinavir-resistant [Comparative Genomic Hybridization (DNA) profiling]
Drug resistance is a major public health challenge in Leishmaniasis chemotherapy, particularly in the case of emerging Leishmania/HIV-1 co-infections. Recently, we have delineated the mechanism of cell death induced by the HIV-1 protease inhibitor, Nelfinavir, in the Leishmania parasite. In order to...
ORGANISM(S): Leishmania donovani 
2013-06-27 | E-GEOD-42195 | biostudies-arrayexpress
UnknownKi67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma.
Not available
S-EPMC11440974 | biostudies-literature
TranscriptomicsLeishmania donovani amastigotes: Nelfinavir (NFV)-sensitive (control) vs Nelfinavir-resistant [RNA expression profiling]
Drug resistance is a major public health challenge in Leishmaniasis chemotherapy, particularly in the case of emerging Leishmania/HIV-1 co-infections. Recently, we have delineated the mechanism of cell death induced by the HIV-1 protease inhibitor, Nelfinavir, in the Leishmania parasite. In order to...
ORGANISM(S): Leishmania donovani 
2013-06-27 | E-GEOD-42196 | biostudies-arrayexpress
TranscriptomicsLeishmania donovani amastigotes: Nelfinavir (NFV)-sensitive (control) vs Nelfinavir-resistant
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Leishmania donovani 
2013-06-27 | E-GEOD-42197 | biostudies-arrayexpress
UnknownAssessment of animal diseases caused by bacteria resistant to antimicrobials: kept fish species.
Not available
S-EPMC8808658 | biostudies-literature
Sort   by:  
 Page size